NovoCure Ltd Annual Return On Equity in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NovoCure Ltd quarterly/annual Return On Equity history and growth rate from 2016 to 2023.
  • NovoCure Ltd Return On Equity for the quarter ending September 30, 2024 was -41.5 %, a 11.5% increase year-over-year.
  • NovoCure Ltd annual Return On Equity for 2023 was -51.6 %, a 146% decline from 2022.
  • NovoCure Ltd annual Return On Equity for 2022 was -21 %, a 43.2% decline from 2021.
  • NovoCure Ltd annual Return On Equity for 2021 was -14.7 %, a 339% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -51.6 -30.7 -146% Jan 1, 2023 Dec 31, 2023
2022 -21 -6.33 -43.2% Jan 1, 2022 Dec 31, 2022
2021 -14.7 -20.8 -339% Jan 1, 2021 Dec 31, 2021
2020 6.13 +10.3 Jan 1, 2020 Dec 31, 2020
2019 -4.17 +52.9 +92.7% Jan 1, 2019 Dec 31, 2019
2018 -57.1 -5.34 -10.3% Jan 1, 2018 Dec 31, 2018
2017 -51.7 +22.8 +30.6% Jan 1, 2017 Dec 31, 2017
2016 -74.5 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.